Key Points
- Dr. Martens insider Ije Nwokori bought 220 shares at GBX 68 each on October 12, for a total of £149.60. This follows purchases of £150.80 in September and £150.36 in August.
- The stock opened at GBX 68 and was down 1.3%, with a market capitalization of approximately £650.9 million and a 12-month trading range of GBX 59.15 to GBX 97.05.
- Analyst sentiment remains positive: Berenberg reaffirmed a “buy” rating with a GBX 110 target, while the consensus rating is “Moderate Buy” with a GBX 105 price target.
Dr. Martens plc (LON:DOCS - Get Free Report) insider Ije Nwokori purchased 220 shares of the company's stock in a transaction dated Monday, October 12th. The shares were bought at an average cost of GBX 68 per share, for a total transaction of £149.60.
Ije Nwokori also recently made the following trade(s):
- On Friday, September 11th, Ije Nwokori purchased 232 shares of Dr. Martens stock. The stock was bought at an average price of GBX 65 per share, with a total value of £150.80.
- On Tuesday, August 11th, Ije Nwokori purchased 179 shares of Dr. Martens stock. The stock was bought at an average price of GBX 84 per share, with a total value of £150.36.
Dr. Martens Stock Down 1.3%
DOCS opened at GBX 68 on Thursday. The company has a quick ratio of 1.13, a current ratio of 2.61 and a debt-to-equity ratio of 108.85. The firm has a 50 day moving average price of GBX 73.62 and a 200-day moving average price of GBX 71.01. Dr. Martens plc has a twelve month low of GBX 59.15 and a twelve month high of GBX 97.05. The stock has a market capitalization of £650.88 million, a price-to-earnings ratio of 28.33, a PEG ratio of 6.40 and a beta of 0.26.
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reaffirmed a "buy" rating and issued a GBX 110 target price on shares of Dr. Martens in a research report on Friday, October 9th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of GBX 105.
Read Our Latest Analysis on DOCS
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot - named after the date it was produced - rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, "Docs" or "DM's" were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.
Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
